These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12367736)

  • 21. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes.
    Braun J; Plantier JC; Hellot MF; Tuaillon E; Gueudin M; Damond F; Malmsten A; Corrigan GE; Simon F
    AIDS; 2003 Feb; 17(3):331-6. PubMed ID: 12556686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement.
    Pyra H; Böni J; Schüpbach J
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1544-8. PubMed ID: 7509077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparable sensitivities for detection of HIV-1 reverse transcriptase (RT) and other polymerases by RT assays requiring no radioisotopic materials.
    Sano K; Odawara F; Nakano T; Morimatsu S; Nakamura T; Saitoh Y; Jiang Y; Misaki H; Sakai Y; Nakai M
    J Virol Methods; 1995 Jun; 53(2-3):235-44. PubMed ID: 7545693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of human immunodeficiency virus type 1 plasma virus load based on reverse transcriptase (RT) activity: evidence of variabilities in levels of virion-associated RT.
    García Lerma JG; Yamamoto S; Gómez-Cano M; Soriano V; Green TA; Busch MP; Folks TM; Heneine W
    J Infect Dis; 1998 May; 177(5):1221-9. PubMed ID: 9593007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay.
    Awad RJ; Corrigan GE; Ekstrand DH; Thorstensson R; Källander CF; Gronowitz JS
    J Clin Microbiol; 1997 May; 35(5):1080-9. PubMed ID: 9114385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemiluminescent enzyme-linked immunoassay for reverse transcriptase, illustrated by detection of HIV reverse transcriptase.
    Suzuki K; Craddock BP; Kano T; Steigbigel RT
    Anal Biochem; 1993 May; 210(2):277-81. PubMed ID: 7685565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A non-radioisotopic reverse transcriptase assay using biotin-11-deoxyuridinetriphosphate on primer-immobilized microtiter plates.
    Urabe T; Sano K; Tanno M; Mizoguchi J; Otani M; Lee MH; Takasaki T; Kusakabe H; Imagawa DT; Nakai M
    J Virol Methods; 1992 Nov; 40(2):145-54. PubMed ID: 1280640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load.
    Villahermosa ML; Thomson M; Vázquez de Parga E; Cuevas MT; Contreras G; Pérez-Alvarez L; Delgado E; Manjón N; Medrano L; Nájera R
    J Hum Virol; 2000; 3(1):27-34. PubMed ID: 10774804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of reverse transcriptase activity by enzyme-linked immunosorbent assay in human immunodeficiency virus type 1.
    Tomita N; Miyahara M; Satoh H; Suzuki K; Kitajima K; Miyamoto K
    Acta Med Okayama; 1995 Apr; 49(2):69-73. PubMed ID: 7542428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorimetric reverse transcriptase assay for HIV-1.
    Suzuki K; Craddock BP; Kano T; Steigbigel RT
    J Virol Methods; 1993 Jan; 41(1):21-8. PubMed ID: 7679395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: relation to RNA copy number and CD4 T-cell count.
    Seyoum E; Wolday D; Girma M; Malmsten A; Meselle T; Gronowitz JS; Britton S
    J Med Virol; 2006 Feb; 78(2):161-8. PubMed ID: 16372295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses.
    Wei X; Liang C; Götte M; Wainberg MA
    AIDS; 2002 Dec; 16(18):2391-8. PubMed ID: 12461412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of 103K/N and 184M/V HIV-1 drug resistant populations: relative comparison in plasma virus RNA versus CD45RO+T cell proviral DNA.
    Jakobsen MR; Tolstrup M; Bertelsen L; Laursen A; Obel N; Ostergaard L; Mohey R
    J Clin Virol; 2007 Jul; 39(3):215-21. PubMed ID: 17540617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.
    Chen R; Yokoyama M; Sato H; Reilly C; Mansky LM
    J Virol; 2005 Sep; 79(18):12045-57. PubMed ID: 16140780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simian-human immunodeficiency virus carrying the rt gene from Chinese CRF01_AE strain of HIV is sensitive to nucleoside reverse transcriptase inhibitors and has a highly genetic stability in vivo.
    Wang W; Yao N; Ju B; Dong Z; Cong Z; Jiang H; Qin C; Wei Q
    Microbes Infect; 2014 Jun; 16(6):461-71. PubMed ID: 24709063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.
    Thrall SH; Reinstein J; Wöhrl BM; Goody RS
    Biochemistry; 1996 Apr; 35(14):4609-18. PubMed ID: 8605212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stable rearrangements of the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase in plasma viruses from patients receiving combination therapy.
    Tamalet C; Izopet J; Koch N; Fantini J; Yahi N
    AIDS; 1998 Oct; 12(14):F161-6. PubMed ID: 9792372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
    Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
    Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.